Timing of Tyrosine Kinase Inhibitor Switching in Chronic Myeloid Leukemia: A Comparative Analysis of Early Versus Late StrategiesChidiebube J. Ugwu, Alankrita Taneja, Folajimi Atunde et al.|Clinical Lymphoma Myeloma & Leukemia|2026Cited by 0